Literature DB >> 25148645

The effect of fibroblast growth factor 9 on the osteogenic differentiation of calvaria-derived mesenchymal cells.

Jingting Lu1, Jiewen Dai, Xudong Wang, Maolin Zhang, Peng Zhang, Hao Sun, XiuLi Zhang, Hongbo Yu, WenBin Zhang, Lei Zhang, Xinquan Jiang, Guofang Shen.   

Abstract

Fibroblast growth factor 9 (FGF9) plays complicated and crucial roles in bone formation, and the biologic effect of FGF9 may depend on the gene dosage, developmental stage, cell type, or interactions with other cytokines. In this study, we demonstrated that FGF9 enhanced the phosphorylation of extracellular regulated protein kinases 1/2 in calvaria-derived mesenchymal cells. However, the inhibitory effect of FGF9 on the osteogenic differentiation of calvaria-derived mesenchymal cells did not depend on the phosphorylation of extracellular regulated protein kinases 1/2. Combined with the previous findings that FGF9 promotes dental pulp stem cells chondrogenesis in vitro, we suggest that FGF9 may be applied to promote chondrogenesis and inhibit osteogenesis in mesenchymal stem cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25148645     DOI: 10.1097/SCS.0000000000001053

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Evidence for Aryl hydrocarbon Receptor-Mediated Inhibition of Osteoblast Differentiation in Human Mesenchymal Stem Cells.

Authors:  AtLee T D Watson; Rachel C Nordberg; Elizabeth G Loboa; Seth W Kullman
Journal:  Toxicol Sci       Date:  2019-01-01       Impact factor: 4.849

2.  Effect of lentivirus-mediated miR-182 targeting FGF9 on hallux valgus.

Authors:  Wei-Lin Zhang; Duo-Yi Zhao; Wei Zhao; Yan Cui; Qin Li; Zhi-Yu Zhang
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.